Owens & Minor, Inc. (OMI) Stock Competitors & Peer Comparison

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, MCK has a market cap of 87.9B. Regarding current trading prices, OMI is priced at $2.68, while MCK trades at $750.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas MCK's P/E ratio is 19.54. In terms of profitability, OMI's ROE is +2.69%, compared to MCK's ROE of -2.65%. Regarding short-term risk, OMI is more volatile compared to MCK. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check MCK's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, COR has a market cap of 52.9B. Regarding current trading prices, OMI is priced at $2.68, while COR trades at $271.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas COR's P/E ratio is 20.81. In terms of profitability, OMI's ROE is +2.69%, compared to COR's ROE of +1.16%. Regarding short-term risk, OMI is more volatile compared to COR. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check COR's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, CAH has a market cap of 51.9B. Regarding current trading prices, OMI is priced at $2.68, while CAH trades at $221.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas CAH's P/E ratio is 33.91. In terms of profitability, OMI's ROE is +2.69%, compared to CAH's ROE of -0.56%. Regarding short-term risk, OMI is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check CAH's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, OMI is priced at $2.68, while ABC trades at $179.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas ABC's P/E ratio is 21.92. In terms of profitability, OMI's ROE is +2.69%, compared to ABC's ROE of +1.16%. Regarding short-term risk, OMI is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check ABC's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, HSIC has a market cap of 9.1B. Regarding current trading prices, OMI is priced at $2.68, while HSIC trades at $79.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas HSIC's P/E ratio is 24.15. In terms of profitability, OMI's ROE is +2.69%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, OMI is more volatile compared to HSIC. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check HSIC's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, OMI is priced at $2.68, while PDCO trades at $31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas PDCO's P/E ratio is 20.48. In terms of profitability, OMI's ROE is +2.69%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, OMI is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check PDCO's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, OMI is priced at $2.68, while GRDN trades at $42.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas GRDN's P/E ratio is 50.49. In terms of profitability, OMI's ROE is +2.69%, compared to GRDN's ROE of +0.27%. Regarding short-term risk, OMI is more volatile compared to GRDN. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check GRDN's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, PBH has a market cap of 2.2B. Regarding current trading prices, OMI is priced at $2.68, while PBH trades at $46.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas PBH's P/E ratio is 12.01. In terms of profitability, OMI's ROE is +2.69%, compared to PBH's ROE of +0.10%. Regarding short-term risk, OMI is more volatile compared to PBH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check PBH's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, ACH has a market cap of 247.4M. Regarding current trading prices, OMI is priced at $2.68, while ACH trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas ACH's P/E ratio is -2.36. In terms of profitability, OMI's ROE is +2.69%, compared to ACH's ROE of +2.65%. Regarding short-term risk, OMI is more volatile compared to ACH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check ACH's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, GEG has a market cap of 86.5M. Regarding current trading prices, OMI is priced at $2.68, while GEG trades at $2.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas GEG's P/E ratio is -3.45. In terms of profitability, OMI's ROE is +2.69%, compared to GEG's ROE of -0.38%. Regarding short-term risk, OMI is less volatile compared to GEG. This indicates potentially lower risk in terms of short-term price fluctuations for OMI.Check GEG's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, OMI is priced at $2.68, while HX trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas HX's P/E ratio is -1.84. In terms of profitability, OMI's ROE is +2.69%, compared to HX's ROE of -1.07%. Regarding short-term risk, OMI is more volatile compared to HX. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check HX's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, WGRX has a market cap of 8.5M. Regarding current trading prices, OMI is priced at $2.68, while WGRX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas WGRX's P/E ratio is -0.08. In terms of profitability, OMI's ROE is +2.69%, compared to WGRX's ROE of +15.45%. Regarding short-term risk, OMI is more volatile compared to WGRX. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check WGRX's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, OMI is priced at $2.68, while ZYXI trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, OMI's ROE is +2.69%, compared to ZYXI's ROE of -18.07%. Regarding short-term risk, OMI is more volatile compared to ZYXI. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check ZYXI's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, SNYR has a market cap of 2.5M. Regarding current trading prices, OMI is priced at $2.68, while SNYR trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas SNYR's P/E ratio is -0.15. In terms of profitability, OMI's ROE is +2.69%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, OMI is less volatile compared to SNYR. This indicates potentially lower risk in terms of short-term price fluctuations for OMI.Check SNYR's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, MEHA has a market cap of 129.5K. Regarding current trading prices, OMI is priced at $2.68, while MEHA trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas MEHA's P/E ratio is -0.06. In terms of profitability, OMI's ROE is +2.69%, compared to MEHA's ROE of +11.59%. Regarding short-term risk, OMI is less volatile compared to MEHA. This indicates potentially lower risk in terms of short-term price fluctuations for OMI.Check MEHA's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, RDGT has a market cap of 364. Regarding current trading prices, OMI is priced at $2.68, while RDGT trades at $1.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas RDGT's P/E ratio is -0.03. In terms of profitability, OMI's ROE is +2.69%, compared to RDGT's ROE of +0.42%. Regarding short-term risk, OMI is more volatile compared to RDGT. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check RDGT's competition here

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 207.1M. In comparison, CVET has a market cap of 0. Regarding current trading prices, OMI is priced at $2.68, while CVET trades at $20.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -0.47, whereas CVET's P/E ratio is -69.97. In terms of profitability, OMI's ROE is +2.69%, compared to CVET's ROE of -0.06%. Regarding short-term risk, OMI is more volatile compared to CVET. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.Check CVET's competition here